Top Premarket Decliners

MT Newswires Live

Mar 09

Olema Pharmaceuticals (OLMA) shares were 42% lower pre-bell Monday following a 4.5% loss in the previous session.

Venu (VENU) stock was down 22% after the company said Sunday it priced a public offering of securities for about $75 million in expected gross proceeds.

Brand Engagement Network (BNAI) shares were 16% lower after the company disclosed in a Form 8-K filing with the US Securities and Exchange Commission that it has received the third installment payment of $506,000 as part of a previously announced private placement of common shares.

Aura Biosciences (AURA) stock was down 11% following a 1.8% loss in the previous session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2618239856"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618239856\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618239856?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618239856","market":"us","top_or_hot":-1,"title":"Top Premarket Decliners","media":"MT Newswires Live","content":"<html><body><p> Olema Pharmaceuticals (OLMA) shares were 42% lower pre-bell Monday following a 4.5% loss in the previous session.</p><p>Venu (VENU) stock was down 22% after the company said Sunday it priced a public offering of securities for about $75 million in expected gross proceeds.</p><p><a href=\"https://laohu8.com/S/BNAI\">Brand Engagement Network</a> (BNAI) shares were 16% lower after the company disclosed in a Form 8-<a href=\"https://laohu8.com/S/TKKD.SI\">K</a> filing with the US Securities and Exchange Commission that it has received the third installment payment of $506,000 as part of a previously announced private placement of common shares.</p><p><a href=\"https://laohu8.com/S/AURA\">Aura Biosciences</a> (AURA) stock was down 11% following a 1.8% loss in the previous session.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-09 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Olema Pharmaceuticals (OLMA) shares were 42% lower pre-bell Monday following a 4.5% loss in the previous session.</p><p>Venu (VENU) stock was down 22% after the company said Sunday it priced a public offering of securities for about $75 million in expected gross proceeds.</p><p><a href=\"https://laohu8.com/S/BNAI\">Brand Engagement Network</a> (BNAI) shares were 16% lower after the company disclosed in a Form 8-<a href=\"https://laohu8.com/S/TKKD.SI\">K</a> filing with the US Securities and Exchange Commission that it has received the third installment payment of $506,000 as part of a previously announced private placement of common shares.</p><p><a href=\"https://laohu8.com/S/AURA\">Aura Biosciences</a> (AURA) stock was down 11% following a 1.8% loss in the previous session.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4134","symbol_name":"信息科技咨询与其它服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2618239856","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618239856","pubTimestamp":1773056594,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Olema Pharmaceuticals  shares were 42% lower pre-bell Monday following a 4.5% loss in the previous session.Venu  stock was down 22% after the company said Sunday it priced a public offering of securities for about $75 million in expected gross proceeds.Brand Engagement Network  shares were 16% lower after the company disclosed in a Form 8-K filing with the US Securities and Exchange Commission that it has received the third installment payment of $506,000 as part of a previously announced private placement of common shares.Aura Biosciences  stock was down 11% following a 1.8% loss in the previous session.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4134":"信息科技咨询与其它服务","BK4209":"餐馆","AURA":"Aura Biosciences, Inc.","VENU":"Venu Holding Corp. (Notes Live, Inc.)","BNAI":"Brand Engagement Network Inc.","OLMA":"Olema Pharmaceuticals, Inc.","BK4505":"高瓴资本持仓","BK4139":"生物科技"},"translate_title":"盘前跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNAI":1,"AURA":1,"VENU":1,"OLMA":1},"content_text":"Olema Pharmaceuticals (OLMA) shares were 42% lower pre-bell Monday following a 4.5% loss in the previous session.Venu (VENU) stock was down 22% after the company said Sunday it priced a public offering of securities for about $75 million in expected gross proceeds.Brand Engagement Network (BNAI) shares were 16% lower after the company disclosed in a Form 8-K filing with the US Securities and Exchange Commission that it has received the third installment payment of $506,000 as part of a previously announced private placement of common shares.Aura Biosciences (AURA) stock was down 11% following a 1.8% loss in the previous session.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}